GBS Inc. Announces Application for FDA Breakthrough Device

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for...

Related Keywords

United States ,American ,Spiro Sakiris ,Asia Pacific ,Tim Mccarthy ,Steven Boyages ,Biosensx North America Inc ,Linkedin ,Lifesci Advisors ,Twitter ,Company Contact ,Drug Administration ,Purpose Of The Program ,Nasdaq ,Life Science Biosensor Diagnostics Pty Ltd ,Gbs Inc ,Exchange Commission ,Breakthrough Devices Program ,Newcastle University ,Devices Breakthrough Program ,Securities Exchange ,Rapid Saliva Glucose Test ,Breakthrough Device ,Breakthrough Program ,Saliva Glucose ,Biosensor Platform ,North America ,North American ,Rapid Saliva Glucose Tests ,Devices Program ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Sci Advisors ,Chief Financial ,Nasdaq Gbs ,Jobs ,Nc ,